Insider Transactions in Q4 2023 at Ventyx Biosciences, Inc. (VTYX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2023
|
John Nuss CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
17,628
-6.3%
|
$35,256
$2.12 P/Share
|
|
Dec 20
2023
|
Raju Mohan CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
58,860
-3.61%
|
$117,720
$2.12 P/Share
|
|
Dec 20
2023
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
5,293
-1.84%
|
$10,586
$2.12 P/Share
|
|
Dec 17
2023
|
Raju Mohan CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
116,668
+6.68%
|
-
|
|
Dec 17
2023
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,479
+3.52%
|
-
|
|
Dec 17
2023
|
John Nuss CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
34,931
+11.1%
|
-
|
|
Oct 09
2023
|
Nsv Partners Iii LP |
SELL
Open market or private sale
|
Indirect |
49,152
-0.58%
|
$1,474,560
$30.03 P/Share
|
|
Oct 09
2023
|
Somu Subramaniam |
SELL
Open market or private sale
|
Indirect |
49,152
-0.58%
|
$1,474,560
$30.03 P/Share
|
|
Oct 05
2023
|
Raju Mohan CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
30,000
-1.94%
|
$870,000
$29.11 P/Share
|
|
Oct 05
2023
|
Raju Mohan CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+1.91%
|
$240,000
$8.04 P/Share
|
|
Oct 03
2023
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-2.58%
|
$450,000
$30.32 P/Share
|
|
Oct 03
2023
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+4.89%
|
$120,000
$8.04 P/Share
|
|
Oct 03
2023
|
John Nuss CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-1.97%
|
$300,000
$30.33 P/Share
|
|
Oct 03
2023
|
John Nuss CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.28%
|
$30,000
$3.93 P/Share
|